Shield Therapeutics Plc (STX) is a UK-listed specialty pharmaceutical company focused on the treatment of iron deficiency, best known for its oral iron therapy marketed under different brand names across regions. The company sits at an interesting stage: past the early development risk, but …
PureTech Health PLC (PRTC) is a biotherapeutics company that builds and advances a portfolio of founded entities, each developing therapies across a range of disease areas. This portfolio model differentiates PureTech from single-asset biotech companies, spreading both risk and opportunity across multiple pipelines.
Renalytix plc is a healthcare diagnostics company focused on developing artificial intelligence-enabled solutions for kidney disease assessment and early detection. The company aims to improve clinical outcomes through advanced diagnostic testing and predictive analytics.
Healthcare investors had a name to discuss on Thursday 2 July 2026 asAllergy Therapeutics (LSE:AGY)advanced 9.84 per cent to close at 6.92 pence, earning the specialty pharmaceutical group a spot among the day's top gaining UK stocks. For a company with a market capitalisation …
Craneware plc is a healthcare software company that provides revenue cycle management, analytics, and financial performance solutions to healthcare providers, particularly hospitals in the United States. The company benefits from long-term demand for digital healthcare solutions and operational efficiency tools.
CelLBxHealth plc has become one of the most actively discussed AIM-listed healthcare companies as investors evaluate whether its precision oncology platform can translate scientific innovation into commercial growth. The company's focus on circulating tumour cell (CTC) technology, cancer diagnostics and research collaborations places it …
• Cambridge Nutritional Sciences remains one of the AIM market's specialist healthcare diagnostics companies focused on nutritional and food intolerance testing.
• Seed Innovations remains one of the AIM market's specialist healthcare investment companies with exposure to biotechnology, medical technology and life sciences businesses.
• 4basebio remains one of the AIM market's leading synthetic DNA technology companies serving the rapidly expanding cell and gene therapy industry.
• Bioventix remains one of the UK's highest-quality specialist life sciences businesses with a global reputation for developing high-affinity monoclonal antibodies used in diagnostic testing.